Literature DB >> 21210541

More co-morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic.

K M van Steenbergen-Weijenburg1, A L van Puffelen, E K Horn, J Nuyen, P Sytze van Dam, T B van Benthem, A T F Beekman, F F H Rutten, L Hakkaart-van Roijen, C M van der Feltz-Cornelis.   

Abstract

AIMS: The impact of depression on patients with chronic medical illnesses such as diabetes is well documented. Depression is relatively common in diabetes patients with diabetes-related complications and they are more likely to be referred to specialized outpatient facilities. Only a few studies have addressed the association between depression and multiple diabetes-related complications at these specialized outpatient facilities. The aim of this study was to determine the association between diabetes with multiple complications and depression in patients with Type 2 diabetes at a specialized outpatient clinic.
METHODS: After giving informed consent, 1194 patients were screened for depression using the Patient Health Questionnaire (PHQ-9). Additional data on the type of diabetes and complications were taken from the medical records. Logistic regression analysis was conducted, with complications as the predictor variable and the probability of depression as the dependent variable.
RESULTS: A total of 596 (63%) patients with Type 2 diabetes participated in the study. The presence of two or more complications (OR 2.23, 95% CI 1.02–2.94) was significantly associated with depression. Neuropathy (OR 1.7, 95% CI 1.10–2.77) and nephropathy (OR 1.68, 95% CI 1.00–2.48) were especially related to depression.
CONCLUSIONS: Patients with Type 2 diabetes with two or more complications, especially neuropathy or nephropathy, are at high risk of depression. Knowing this can help clinicians identify patients at risk for depression and facilitate timely and adequate treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21210541     DOI: 10.1111/j.1464-5491.2010.03125.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  Validation of the Comprehensive International Classification of Functioning, Disability and Health (ICF) Core Set for Diabetes Mellitus in patients with diabetic nephropathy.

Authors:  Hideyo Tsutsui; Toshiyuki Ojima; Nobuaki Ozaki; Masataka Kusunoki; Tetsuya Ishiguro; Yoshiharu Oshida
Journal:  Clin Exp Nephrol       Date:  2014-05-20       Impact factor: 2.801

2.  IL-1β, IL-6, IL-8, IL-10, IFN-γ, TNF-α and its relationship with lipid parameters in patients with major depression.

Authors:  Cicek Hocaoglu; Birgul Kural; Rezzan Aliyazıcıoglu; Orhan Deger; Sevil Cengiz
Journal:  Metab Brain Dis       Date:  2012-06-19       Impact factor: 3.584

Review 3.  Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.

Authors:  J R Miranda-Massari; M J Gonzalez; F J Jimenez; M Z Allende-Vigo; J Duconge
Journal:  Curr Clin Pharmacol       Date:  2011-11

4.  Risk factors for depressive symptoms in a large population on chronic hemodialysis.

Authors:  Sônia M H A Araujo; Veralice M S de Bruin; Elizabeth de F Daher; Gilson H Almeida; Camila A M Medeiros; Pedro Felipe C de Bruin
Journal:  Int Urol Nephrol       Date:  2011-07-22       Impact factor: 2.370

5.  Effects of motivational enhancement therapy plus cognitive behaviour therapy on depressive symptoms and health-related quality of life in adults with type II diabetes mellitus: a randomised controlled trial.

Authors:  Chiung-Yu Huang; Hui-Ling Lai; Chun-I Chen; Yung-Chuan Lu; Su-Chen Li; Long-Whou Wang; Yi Su
Journal:  Qual Life Res       Date:  2015-10-26       Impact factor: 4.147

Review 6.  Diabetes and depression.

Authors:  Richard I G Holt; Mary de Groot; Sherita Hill Golden
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

Review 7.  The comorbidity between depression and diabetes.

Authors:  Bibilola D Oladeji; Oye Gureje
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

8.  Prevalence and influencing factors of co-morbid depression in patients with type 2 diabetes mellitus: a General Hospital based study.

Authors:  Weijun Zhang; Huiwen Xu; Shuliang Zhao; Shinan Yin; Xiaohua Wang; Jing Guo; Shengfa Zhang; Huixuan Zhou; Fugang Wang; Linni Gu; Lei Zhu; Haibo Yu; Zhiyong Qu; Donghua Tian
Journal:  Diabetol Metab Syndr       Date:  2015-06-30       Impact factor: 3.320

9.  Induction of anxiolytic, antidepressant and analgesic effects by Shiff base of (E)-3-(1H-imidazol-4-yl)-2-((2-oxoindolin-3-ylidene)amino)propanoic acid derivatives in diabetic rats.

Authors:  Mohaddese Goleij; Leila Youseftabar-Miri; Maryam Montazeri; Fatemeh Khakpai
Journal:  J Diabetes Metab Disord       Date:  2021-01-03

Review 10.  Depression and postoperative complications: an overview.

Authors:  Mohamed M Ghoneim; Michael W O'Hara
Journal:  BMC Surg       Date:  2016-02-02       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.